Chong Kun Dang Holdings Corp. (KRX:001630)
South Korea · Delayed Price · Currency is KRW 35,550
-50 (-0.14%)
Oct 23, 2026, 3:30 PM KST
Chong Kun Dang Holdings Market Cap
Chong Kun Dang Holdings has a market cap or net worth of 169.24 billion as of October 23, 2026. It is the 23,464th most valuable company in the world and the 921st biggest in South Korea. Its market cap has decreased by 24.52% in one year.
Market Cap
169.24B
Enterprise Value
895.57B
Revenue
961.64B
Global Rank
Country Rank
#921 South Korea
PE Ratio
3.25
ChartMarket Cap Chart
Since July 9, 1992, Chong Kun Dang Holdings's market cap has increased from 43.10B to 169.24B, an increase of 292.64%. That is a compound annual growth rate of 4.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 169.24B | -23.14% |
| Dec 30, 2025 | 220.18B | -3.04% |
| Dec 30, 2024 | 227.08B | -19.63% |
| Dec 28, 2023 | 282.55B | 9.42% |
| Dec 29, 2022 | 258.23B | -31.93% |
| Dec 30, 2021 | 379.33B | -40.61% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Whan In Pharm | 188.54B |
| Hyundai Pharmaceutical | 187.93B |
| Yungjin Pharm. | 180.33B |
| REYON Pharmaceutical | 178.64B |
| Samil Pharmaceutical Co.,Ltd | 175.88B |
| AptaBio Therapeutics | 175.30B |
| BNC KOREA | 175.09B |
| Daewon Pharmaceutical | 170.18B |